Filgrastim biosimilar (Dong-A)

非格司亭生物类似药（Dong-A）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Dong-A)
Drug Alias Name重组人粒细胞刺激因子（Dong-A）rhG-CSF (Dong-A)Recombinant human granulocyte macrophage colony stimulating factor (Dong-A)非格司亭生物仿制药（Dong-A）Leukostim +[6] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsNeutropeniaDiabetic Neuropathies
Global Approved IndicationsNeutropenia
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date1999/01/01
Country/TerritorySouth AfricaSouth KoreaIndonesia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDong-A Pharmaceutical Co Ltd
Inactive CompaniesUniversity Of MissouriDong-A ST Co Ltd
Active IndicationsNeutropenia
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsDiabetic Neuropathies

Other Information

ATC CodeL03AA02
Related LinksN/A